Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy

Epilepsia

Volumn 52, Issue 3, 2011, Pages 551-561

  Musto, Alberto E ^a   Samii, Mark ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Epileptogenesis; Kindling; Neuroinflammation; Neuroprotection; Platelet activating factor; Seizures; Somatostatin

Indexed keywords

2,4,6 TRIMETHYL 1,4 DIHYDRO 3,5 PYRIDINEDICARBOXYLIC ACID 2 (3,4 DICHLOROPHENOXY)ETHYL BIS(MORPHOLINOMETHYL)METHYL ESTER; 2,4,6 TRIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLIC ACID ESTER; PILOCARPINE; SOMATOSTATIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TARGETING; EPILEPSY; EPILEPTIC STATE; HIPPOCAMPUS; INFLAMMATION; KINDLING; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL EXCITABILITY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY;

ANIMALS; CELL DEATH; CYTOKINES; DIHYDROPYRIDINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79952552282     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02920.x     Document Type: Article

References (67)

1. Akiyama K, Ishikawa M, Saito A. (2008) mRNA expression of activity-regulated cytoskeleton-associated protein (arc) in the amygdala-kindled rats. Brain Res 1189:236-246.
2. André V, Ferrandon A, Marescaux C, Nehlig A. (2001) Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 47:99-117. (Pubitemid 32973652)
3. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA. (2010) Expression pattern of miR-146a, an inflammation- associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 31:1100-1107.
4. Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E. (2008) Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 28:9133-9144.
5. Bazan NG. (2006) Eicosanoids, docosanoids, platelet-activating factor and inflammation. In Siegel G, Albers RW, Brady S, Price D (Eds) Basic neurochemistry. 7th ed. Elsevier, London, UK, pp. 575-591.
6. Bazan NG. (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136-141.
7. Belayev L, Khoutorova L, Atkins K, Gordon WC, Alvarez-Builla J, Bazan NG. (2008) LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Exp Neurol 214:253-258.
8. Belayev L, Khoutorova L, Atkins KD, Bazan NG. (2009) Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 40:3121-3126.
9. Blackbeard J, O'Dea KP, Wallace VC, Segerdahl A, Pheby T, Takata M, Field MJ, Rice AS. (2007) Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. J Neurosci Methods 164: 207-217. (Pubitemid 47018274)
10. Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. (1998) Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4:1166-1172. (Pubitemid 28468830)
11. Cavalheiro EA, Mello ML, Leite JP. (2006) The pilocarpine model of seizures. In Pitkanen A, Schwartzkroin PA, Moshe SL (Eds) Models of seizures and epilepsy. Elsevier, Burlington, MA, pp. 433-448.
12. Chen C, Magee JC, Marcheselli V, Hardy M, Bazan NG. (2001) Attenuated LTP in hippocampal dentate gyrus neurons of mice deficient in the PAF receptor. J Neurophysiol 85:384-390. (Pubitemid 32062148)
13. Chen Z, Duan RS, Q HC, Wu Q, Mix E, Winblad B, Ljunggren HG, Zhu J. (2004) IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice. Neurobiol Dis 17:171-178. (Pubitemid 39345773)
14. Christensen KV, Leffers H, Watson WP, Sánchez C, Kallunki P, Egebjerg J. (2010) Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdalakindled rats. BMC Neurosci 27:11-19.
15. Coggeshall RE, Lekan HA. (1996) Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364:6-15. (Pubitemid 26026631)
16. Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF. (1997) Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79:163-175. (Pubitemid 27502035)
17. Cole-Edwards KK, Musto AE, Bazan NG. (2006) c-Jun N-terminal kinase activation responses induced by hippocampal kindling are mediated by reactive astrocytes. J Neurosci 26:8295-8304. (Pubitemid 44309843)
18. Crespel A, Coubes P, Rousset MC, Brana C, Rougier A, Rondouin G, Bockaert J, Baldy-Moulinier M, Lerner-Natoli M. (2002) Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 952:159-169.
19. Croucher MJ, Marriott DR, Bradford HF, Wilkin GP. (1991) Lack of effect of focally administered prostaglandins on electrically kindled seizure activity. Prostaglandins 42:29-38.
20. Dinocourt C, Petanjek Z, Freund TF, Ben-Ari Y, Esclapez M. (2003) Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine-induced seizures. J Comp Neurol 459:407-425. (Pubitemid 36438288)
21. Dudek FE, Staley KJ, Sutula TP. (2002) The search for animal models of epileptogenesis and pharmacoresistance: are there biologic barriers to simple validation strategies? Epilepsia 43:1275-1277.
22. El-Hassar L, Esclapez M, Bernard C. (2007) Hyperexcitability of the CA1 hippocampal region during epileptogenesis. Epilepsia 48:131-139. (Pubitemid 47512214)
23. Gavilán MP, Revilla E, Pintado C, Castaño A, Vizuete ML, Moreno-González I, Baglietto-Vargas D, Sánchez-Varo R, Vitorica J, Gutiérrez A, Ruano D. (2007) Molecular and cellular characterization of the age-related neuroinflammatory processes occurring in normal rat hippocampus: potential relation with the loss of somatostatin GABAergic neurons. J Neurochem 103:984-996. (Pubitemid 47568716)
24. Gibbs JW III, Sombati S, DeLorenzo RJ, Coulter DA. (1997) Physiological and pharmacological alterations in postsynaptic GABA(A) receptor function in a hippocampal culture model of chronic spontaneous seizures. J Neurophysiol 77:2139-2152. (Pubitemid 27174999)
25. Goddard GV, McIntyre DC, Leech CK. (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295-330.
26. Goffin K, Nissinen J, Van Laere K, Pitkänen A. (2007) Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat. Exp Neurol 205:501-505. (Pubitemid 46755770)
27. Izumi T, Honda Z, Mutoh H, Kume K, Shimizu T. (1995) Regulation and signal transduction of PAF receptor. Adv Prostaglandin Thromboxane Leukot Res 23:461-466.
28. Kapur J, Coulter DA. (1995) Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons. Ann Neurol 38:893-900. (Pubitemid 26004071)
29. Kapur J, Lothman EW. (1989) Loss of inhibition precedes delayed spontaneous seizures in the hippocampus after tetanic electrical stimulation. J Neurophysiol 61:427-434. (Pubitemid 19063456)
30. Kato K, Clark GD, Bazan NG, Zorumski CF. (1994) Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal longterm potentiation. Nature 367:175-179. (Pubitemid 24031698)
31. Khurgel M, Ivy GO. (1996) Astrocytes in kindling: relevance to epileptogenesis. Epilepsy Res 26:163-175. (Pubitemid 26420740)
32. Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. (1991) PAF. A review of its effects, antagonists and possible future clinical implications (Part II). Drugs 42:174-204.
33. Kovács Z, Kékesi KA, Szilágyi N, Abrahám I, Székács D, Király N, Papp E, Császár I, Szego E, Barabás K, Péterfy H, Erdei A, Bártfai T, Juhász G. (2006) Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience 140: 731-742.
34. Lothman EW, Hatlelid JM, Zorumski CF, Conry JA, Moon PF, Perlin JB. (1985) Kindling with rapidly recurring hippocampal seizures. Brain Res 360:83-91. (Pubitemid 16171004)
35. Marcheselli VL, Rossowska MJ, Domingo MT, Braquet P, Bazan NG. (1990) Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem 265:9140-9145.
36. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG. (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278:43807-43817. (Pubitemid 37346009)
37. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D. (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33:171-181.
38. Marcon J, Gagliardi B, Balosso S, Maroso M, Noé F, Morin M, Lerner- Natoli M, Vezzani A, Ravizza T. (2009) Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis 34:121-132.
39. Mello LE, Covolan L. (1996) Spontaneous seizures preferentially injure interneurons in the pilocarpine model of chronic spontaneous seizures. Epilepsy Res 26:123-129. (Pubitemid 26420736)
40. Morimoto K, Fahnestock M, Racine RJ. (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:1-60. (Pubitemid 38749090)
41. Mukherjee PK, DeCoster MA, Campbell FZ, Davis RJ, Bazan NG. (1999) Glutamate receptor signaling interplay modulates stress-sensitive mitogen- activated protein kinases and neuronal cell death. J Biol Chem 274:6493-6498. (Pubitemid 29111065)
42. Musto AE, Samii MS, Hayes JF. (2009) Different phases of afterdischarge during rapid kindling procedure in mice. Epilepsy Res 85:199-205.
43. Okamoto OK, Janjoppi L, Bonone FM, Pansani AP, da Silva AV, Scorza FA, Cavalheiro EA. (2010) Whole transcriptome analysis of the hippocampus: toward a molecular portrait of epileptogenesis. BMC Genomics 11:230.
44. Oliveira MS, Furian AF, Royes LF, Fighera MR, Fiorenza NG, Castelli M, Machado P, Bohrer D, Veiga M, Ferreira J, Cavalheiro EA, Mello CF. (2008) Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res 79:14-21.
45. Petilla Interneuron Nomenclature Group; Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, Buzsáki G, Cauli B, Defelipe J, Fairén A, Feldmeyer D, Fishell G, Fregnac Y, Freund TF, Gardner D, Gardner EP, Goldberg JH, Helmstaedter M, Hestrin S, Karube F, Kisvárday ZF, Lambolez B, Lewis DA, Marin O, Markram H, Muñoz A, Packer A, Petersen CC, Rockland KS, Rossier J, Rudy B, Somogyi P, Staiger JF, Tamas G, Thomson AM, Toledo-Rodriguez M, Wang Y, West DC, Yuste R. (2008) Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci 9:557-568. (Pubitemid 351873463)
46. Plata-Salamán CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Romanovitch AE, Kelly ME, Bureau Y, Anisman H, McIntyre DC. (2000) Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res 75:248-258. (Pubitemid 30109275)
47. Polascheck N, Bankstahl M, Löscher W. (2010) The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol 224:219-233.
48. Press WB, Teukolsky SA, Vetterling WT, Flannery BP. (1992) Numerical recipes in C. the art of scientific computing. 2nd ed. Cambridge University Press, UK.
49. Racine RJ. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.
50. Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M, Vezzani A. (2008) Interleukin Converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-beta production. Neurobiol Dis 31:327-333.
51. Rodgers KM, Hutchinson MR, Northcutt A, Maier SF, Watkins LR, Barth DS. (2009) The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 132:2478-2486.
52. Sanabria ER, Su H, Yaari Y. (2001) Initiation of network bursts by Ca2+- dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy. J Physiol 532:205-216. (Pubitemid 32303283)
53. Sankar R, Auvin S, Kwon YS, Pineda E, Shin D, Mazarati A. (2010) Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling. Epilepsia 3:39-42.
54. Sayyah M, Najafabadi IT, Beheshti S, Majzoob S. (2003) Lipopolysaccharide retards development of amygdala kindling but does not affect fully-kindled seizures in rats. Epilepsy Res 57:175-180. (Pubitemid 38167734)
55. Shandra AA, Godlevsky LS, Vastyanov RS, Oleinik AA, Konovalenko VL, Rapoport EN, Korobka NN. (2002) The role of TNF-alpha in amygdala kindled rats. Neurosci Res 42:147-153. (Pubitemid 34155372)
56. Squinto SP, Block AL, Braquet P, Bazan NG. (1989) Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells. J Neurosci Res 24:558-566. (Pubitemid 20015348)
57. Stewart LS, Leung LS. (2003) Temporal lobe seizures alter the amplitude and timing of rat behavioral rhythms. Epilepsy Behav 4:153-160. (Pubitemid 37184587)
58. Takemiya T, Suzuki K, Sugiura H, Yasuda S, Yamagata K, Kawakami Y, Maru E. (2003) Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat 71:205-216. (Pubitemid 36929791)
59. Teather LA, Wurtman RJ. (2003) Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes. Neurosci Lett 340:177-180. (Pubitemid 36369667)
60. Titulaer MN, Kamphuis W, Lopes da Silva FH. (1995) Autoradiographic analysis of [35S]t-butylbicyclophosphorothionate binding in kindled rat hippocampus shows different changes in CA1 area and fascia dentata. Neuroscience 66:547-554.
61. Tu B, Bazan NG. (2003) Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 179:167-175. (Pubitemid 36279616)
62. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA. (1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3:154-171.
63. Vezzani A, Granata T. (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:1724-1743. (Pubitemid 44921957)
64. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T, Perego C, De Simoni MG. (2002) Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43(suppl 5):30-35. (Pubitemid 34864203)
65. Vezzani A, Ravizza T, Balosso S, Aronica E. (2008) Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49(Suppl 2):24-32. (Pubitemid 351143763)
66. Voutsinos-Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A, Motte J. (2004) Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 17:385-402. (Pubitemid 39574873)
67. Wu K, Leung LS. (2003) Increased dendritic excitability in hippocampal ca1 in vivo in the kainic acid model of temporal lobe epilepsy: a study using current source density analysis. Neuroscience 116:599-616. (Pubitemid 36139930)